The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.505
https://www.valueinhealthjournal.com/article/S1098-3015(16)31872-1/fulltext
Title :
The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31872-1&doi=10.1016/j.jval.2016.09.505
First page :
A434
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
477